These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23753029)

  • 1. In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline.
    Mendler JH; Maharry K; Becker H; Eisfeld AK; Senter L; Mrózek K; Kohlschmidt J; Metzeler KH; Schwind S; Whitman SP; Khalife J; Caligiuri MA; Klisovic RB; Moore JO; Carter TH; Marcucci G; Bloomfield CD
    Haematologica; 2013 Aug; 98(8):e92-4. PubMed ID: 23753029
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases". Haematologica 2014;99(2):e20-21.
    Mendler JH; Marcucci G; Bloomfield CD
    Haematologica; 2014 Feb; 99(2):e22. PubMed ID: 24497566
    [No Abstract]   [Full Text] [Related]  

  • 3. Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases.
    Fasan A; Haferlach C; Kohlmann A; Dicker F; Eder C; Kern W; Haferlach T; Schnittger S
    Haematologica; 2014 Feb; 99(2):e20-1. PubMed ID: 24497565
    [No Abstract]   [Full Text] [Related]  

  • 4. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
    Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
    Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for germline mutations in the
    Bąk A; Skonieczka K; Jaśkowiec A; Junkiert-Czarnecka A; Heise M; Pilarska-Deltow M; Potoczek S; Czyżewska M; Haus O
    Leuk Lymphoma; 2021 Jul; 62(7):1749-1755. PubMed ID: 33563056
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Pasca S; Jurj A; Tomuleasa C; Zdrenghea M
    Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33255417
    [No Abstract]   [Full Text] [Related]  

  • 7. RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.
    Greif PA; Konstandin NP; Metzeler KH; Herold T; Pasalic Z; Ksienzyk B; Dufour A; Schneider F; Schneider S; Kakadia PM; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
    Haematologica; 2012 Dec; 97(12):1909-15. PubMed ID: 22689681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
    Mendler JH; Maharry K; Radmacher MD; Mrózek K; Becker H; Metzeler KH; Schwind S; Whitman SP; Khalife J; Kohlschmidt J; Nicolet D; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
    J Clin Oncol; 2012 Sep; 30(25):3109-18. PubMed ID: 22753902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX1 germline variants in RUNX1-mutant AML: how frequent?
    Ernst MPT; Kavelaars FG; Löwenberg B; Valk PJM; Raaijmakers MHGP
    Blood; 2021 Mar; 137(10):1428-1431. PubMed ID: 33075818
    [No Abstract]   [Full Text] [Related]  

  • 10. High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.
    Simon L; Spinella JF; Yao CY; Lavallée VP; Boivin I; Boucher G; Audemard E; Bordeleau ME; Lemieux S; Hébert J; Sauvageau G
    Blood; 2020 May; 135(21):1882-1886. PubMed ID: 32315381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.
    Dicker F; Haferlach C; Sundermann J; Wendland N; Weiss T; Kern W; Haferlach T; Schnittger S
    Leukemia; 2010 Aug; 24(8):1528-32. PubMed ID: 20520634
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited
    Prieto-Conde MI; Labrador J; Hermida G; Alonso S; Jiménez C; García-Álvarez M; Medina A; Balanzategui A; Alcoceba M; Sarasquete ME; Puig N; González V; Gutiérrez NC; García-Sanz R; González-Díaz M; Chillón MDC
    Leuk Lymphoma; 2020 Jan; 61(1):181-184. PubMed ID: 31385734
    [No Abstract]   [Full Text] [Related]  

  • 13. NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification.
    Weinberg OK; Gibson CJ; Blonquist TM; Neuberg D; Pozdnyakova O; Kuo F; Ebert BL; Hasserjian RP
    Am J Hematol; 2017 Jul; 92(7):E123-E124. PubMed ID: 28370403
    [No Abstract]   [Full Text] [Related]  

  • 14. Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies.
    Sakurai M; Nannya Y; Yamazaki R; Yamaguchi K; Koda Y; Abe R; Yokoyama K; Ogawa S; Mori T
    Ann Hematol; 2022 Jan; 101(1):237-239. PubMed ID: 33462643
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary thrombocytopenia and acute myeloid leukemia: a common link due to a germline mutation in the AML1 gene.
    Appelmann I; Linden T; Rudat A; Mueller-Tidow C; Berdel WE; Mesters RM
    Ann Hematol; 2009 Oct; 88(10):1037-8. PubMed ID: 19337732
    [No Abstract]   [Full Text] [Related]  

  • 16. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.
    Tang JL; Hou HA; Chen CY; Liu CY; Chou WC; Tseng MH; Huang CF; Lee FY; Liu MC; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Lin LI; Tien HF
    Blood; 2009 Dec; 114(26):5352-61. PubMed ID: 19808697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
    Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY
    Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial leukemia due to germline RUNX1 mutations: lessons learned from two decades of research and unsolved problems].
    Osato M; Nambu A
    Rinsho Ketsueki; 2020; 61(6):687-696. PubMed ID: 32624544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
    Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
    Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
    [No Abstract]   [Full Text] [Related]  

  • 20. To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition.
    Avagyan S; Brown AL
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.